Works matching IS 02683369 AND DT 2010 AND VI 45 AND IP 6

Results: 31

Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: risk factors, therapy and outcome.

Published in:

2010

By:

Chaplow, R.;
Palmer, B.;
Heyderman, R.;
Moppett, J.;
Marks, D. I.

Publication type:

Letter

Long-term results of rituximab treatment for membranous nephropathy after allogeneic hematopoietic SCT: a case report.

Published in:

2010

By:

Mattei, D.;
Sorasio, R.;
Guarnieri, A.;
Marazzi, F.;
Formica, M.;
Fortunato, M.;
Mordini, N.;
Rapezzi, D.;
Gallamini, A.

Publication type:

Letter

The combination method using magnetic beads and a magnet helps sustain the number of donor BM cells after intra-BM injection, resulting in rapid hematopoietic recovery.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 993, doi. 10.1038/bmt.2009.278

By:

Shima, C.;
Adachi, Y.;
Shi, M.;
Imai, Y.;
Okigaki, M.;
Yanai, S.;
Minamino, K.;
Takahashi, K.;
Ikehara, S.

Publication type:

Article

Sudden loss of the GVL effect following use of the TNF inhibitor infliximab in a chronic myelogenous leukemia patient with chronic GVHD.

Published in:

2010

By:

Veeraputhiran, M.;
Mangan, K.

Publication type:

Letter

CD3+ and/or CD14+ depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34+ cell yields.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1000, doi. 10.1038/bmt.2009.289

By:

Yang, H.;
Robinson, S. N.;
Lu, J.;
Decker, W. K.;
Xing, D.;
Steiner, D.;
Parmar, S.;
Shah, N.;
Champlin, R. E.;
Munsell, M.;
Leen, A.;
Bollard, C.;
Simmons, P. J.;
Shpall, E. J.

Publication type:

Article

Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient.

Published in:

2010

By:

Oosterhof, L.;
Christensen, C. B.;
Sengeløv, H.

Publication type:

Letter

Late extramedullary relapse after allogeneic transplantation in a case of variant hairy cell leukaemia.

Published in:

2010

By:

Busemann, C.;
Schüler, F.;
Krüger, W.;
Kiefer, T.;
Wuppermann, M.;
Androshchuk, M.;
Dölken, G.

Publication type:

Letter

Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.

Published in:

2010

By:

Magni, M.;
Di Nicola, M.;
Carlo-Stella, C.;
Devizzi, L.;
Guidetti, A.;
Matteucci, P.;
Gianni, A. M.

Publication type:

Letter

Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF.

Published in:

2010

By:

Nimmagadda, S.;
Sweiss, K.;
Mahmud, N.;
Park, Y.;
Rondelli, D.

Publication type:

Letter

Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1008, doi. 10.1038/bmt.2009.296

By:

Piccin, A.;
McCann, S.;
Socié, G.;
Oneto, R.;
Bacigalupo, A.;
Locasciulli, A.;
Marsh, J.;
Schrezenmeier, H.;
Tichelli, A.;
Hand, E.;
Lawler, M.;
Passweg, J.

Publication type:

Article

Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1047, doi. 10.1038/bmt.2009.298

By:

Frugnoli, I.;
Cappelli, B.;
Chiesa, R.;
Biral, E.;
Noè, A.;
Evangelio, C.;
Fossati, M.;
Napolitano, S.;
Ciceri, F.;
Roncarolo, M. G.;
Marktel, S.

Publication type:

Article

CsA exposure is associated with acute GVHD and relapse in children after SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1056, doi. 10.1038/bmt.2009.299

By:

Willemze, A. J.;
Press, R. R.;
Lankester, A. C.;
Egeler, R. M.;
den Hartigh, J.;
Vossen, J. M.

Publication type:

Article

Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1062, doi. 10.1038/bmt.2009.301

By:

Mawardi, H.;
Stevenson, K.;
Gokani, B.;
Soiffer, R.;
Treister, N.

Publication type:

Article

Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1052, doi. 10.1038/bmt.2009.302

By:

Faraci, M.;
Caviglia, I.;
Morreale, G.;
Lanino, E.;
Cuzzubbo, D.;
Giardino, S.;
Di Marco, E.;
Cirillo, C.;
Scuderi, F.;
Dallorso, S.;
Terranova, P.;
Moroni, C.;
Castagnola, E.

Publication type:

Article

Effect of missing killer-immunoglobulin-like receptor ligand in recipients undergoing HLA full matched, non-T-depleted sibling donor transplantation: a single institution experience of 151 Asian patients.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1031, doi. 10.1038/bmt.2009.303

By:

Linn, Y. C.;
Phang, C. Y.;
Lim, T. J.;
Chong, S. F.;
Heng, K. K.;
Lee, J. J.;
Loh, Y.;
Hwang, W.;
Goh, Y. T.;
Koh, M.

Publication type:

Article

Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1038, doi. 10.1038/bmt.2009.304

By:

Yoon, S. R.;
Lee, Y. S.;
Yang, S. H.;
Ahn, K. H.;
Lee, Je-H.;
Lee, Ju-H.;
Kim, D. Y.;
Kang, Y. A.;
Jeon, M.;
Seol, M.;
Ryu, S. G.;
Chung, J. W.;
Choi, I.;
Lee, K. H.

Publication type:

Article

Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1014, doi. 10.1038/bmt.2009.305

By:

Tappenden, P.;
Saccardi, R.;
Confavreux, C.;
Sharrack, B.;
Muraro, P. A.;
Mancardi, G. L.;
Kozak, T.;
Farge-Bancel, D.;
Madan, J.;
Rafia, R.;
Akehurst, R.;
Snowden, J.

Publication type:

Article

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1068, doi. 10.1038/bmt.2009.307

By:

Shaughnessy, P. J.;
Bolwell, B. J.;
van Besien, K.;
Mistrik, M.;
Grigg, A.;
Dodds, A.;
Prince, H. M.;
Durrant, S.;
Ilhan, O.;
Parenti, D.;
Gallo, J.;
Foss, F.;
Apperley, J.;
Zhang, M.-J.;
Horowitz, M. M.;
Abhyankar, S.

Publication type:

Article

Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies.

Published in:

2010

By:

Horacek, J. M.;
Jebavy, L.;
Ulrychova, M.;
Tichy, M.;
Pudil, R.;
Zak, P.;
Maly, J.

Publication type:

Letter

Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1095, doi. 10.1038/bmt.2009.308

By:

Giebel, S.;
Stella-Holowiecka, B.;
Krawczyk-Kulis, M.;
Gökbuget, N.;
Hoelzer, D.;
Doubek, M.;
Mayer, J.;
Piatkowska-Jakubas, B.;
Skotnicki, A. B.;
Dombret, H.;
Ribera, J. M.;
Piccaluga, P. P.;
Czerw, T.;
Kyrcz-Krzemien, S.;
Holowiecki, J.

Publication type:

Article

Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1102, doi. 10.1038/bmt.2009.309

By:

Vrijmoet-Wiersma, C. M. J.;
Egeler, R. M.;
Koopman, H. M.;
Bresters, D.;
Norberg, A. L.;
Grootenhuis, M. A.

Publication type:

Article

Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation.

Published in:

2010

By:

Conchon, M.;
Sanabani, S. S.;
Bendit, I.;
Serpa, M.;
Filho, U. A.;
de Barros Ferreira, P.;
Novaes, M. M. Y.;
Saboya, R.;
Llacer-Dorliac, P. E.;
Dulley, F. L.

Publication type:

Letter

The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 985, doi. 10.1038/bmt.2009.311

By:

Xu, L.-P.;
Liu, K.-Y.;
Liu, D.-H.;
Chen, H.;
Han, W.;
Chen, Y.-H.;
Wang, Y.;
Huang, X.-J.

Publication type:

Article

Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1077, doi. 10.1038/bmt.2009.312

By:

Wang, Y.;
Ogawa, Y.;
Dogru, M.;
Tatematsu, Y.;
Uchino, M.;
Kamoi, M.;
Okada, N.;
Okamoto, S.;
Tsubota, K.

Publication type:

Article

Specific self-antigen-driven immune response in pericardial effusion as an isolated GVHD manifestation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1084, doi. 10.1038/bmt.2009.314

By:

Lev, A.;
Amariglio, N.;
Spirer, Z.;
Katz, U.;
Bielorai, B.;
Rechavi, G.;
Somech, R.

Publication type:

Article

Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1088, doi. 10.1038/bmt.2009.316

By:

Kimura, S.;
Oshima, K.;
Okuda, S.;
Sato, K.;
Sato, M.;
Terasako, K.;
Nakasone, H.;
Kako, S.;
Yamazaki, R.;
Tanaka, Y.;
Tanihara, A.;
Higuchi, T.;
Nishida, J.;
Kanda, Y.

Publication type:

Article

Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1022, doi. 10.1038/bmt.2009.384

By:

Giebel, S.;
Dziaczkowska, J.;
Czerw, T.;
Wojnar, J.;
Krawczyk-Kulis, M.;
Nowak, I.;
Holowiecka, A.;
Segatti, A.;
Kyrcz-Krzemien, S.;
Kusnierczyk, P.;
Holowiecki, J.

Publication type:

Article

In memoriam: Stefan Thierfelder.

Published in:

2010

By:

Kolb, H.-J.

Publication type:

Obituary

Reconstitution of repertoire of natural killer cell receptors after transplantation: just a question of time?

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 968, doi. 10.1038/bmt.2010.116

By:

Locatelli, F.;
Bertaina, A.

Publication type:

Article

CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 979, doi. 10.1038/bmt.2010.35

By:

Reddy, S. M.;
Winston, D. J.;
Territo, M. C.;
Schiller, G. J.

Publication type:

Article

Quality rather than quantity: the cord blood bank dilemma.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 970, doi. 10.1038/bmt.2010.7

By:

Querol, S.;
Gomez, S. G.;
Pagliuca, A.;
Torrabadella, M.;
Madrigal, J. A.

Publication type:

Article

Works matching IS 02683369 AND DT 2010 AND VI 45 AND IP 6

Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: risk factors, therapy and outcome.

Long-term results of rituximab treatment for membranous nephropathy after allogeneic hematopoietic SCT: a case report.

The combination method using magnetic beads and a magnet helps sustain the number of donor BM cells after intra-BM injection, resulting in rapid hematopoietic recovery.

Sudden loss of the GVL effect following use of the TNF inhibitor infliximab in a chronic myelogenous leukemia patient with chronic GVHD.

CD3<sup>+</sup> and/or CD14<sup>+</sup> depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34<sup>+</sup> cell yields.

Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient.

Late extramedullary relapse after allogeneic transplantation in a case of variant hairy cell leukaemia.

Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.

Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF.

Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT.

Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia.

CsA exposure is associated with acute GVHD and relapse in children after SCT.

Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD.

Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children.

Effect of missing killer-immunoglobulin-like receptor ligand in recipients undergoing HLA full matched, non-T-depleted sibling donor transplantation: a single institution experience of 151 Asian patients.

Generation of donor natural killer cells from CD34<sup>+</sup> progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study.

Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.

Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies.

Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL.

Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT.

Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation.

The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis.

Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye.

Specific self-antigen-driven immune response in pericardial effusion as an isolated GVHD manifestation.

Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.

Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT.

In memoriam: Stefan Thierfelder.

Reconstitution of repertoire of natural killer cell receptors after transplantation: just a question of time?

CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency.

Quality rather than quantity: the cord blood bank dilemma.